The expression levels of CXCL10, TREX1 and PRMT1 in DLBCL patients versus healthy controls were analyzed using the Gene Expression Profiling Interactive Analysis 2 (GEPIA2) tool. This evidence concerns the gene CXCL10 and diffuse large B-cell lymphoma.